Goldman Sachs Resumes Roivant Sciences (ROIV) at Buy

July 10, 2025 5:08 AM EDT Send to a Friend
(Updated - July 10, 2025 6:26 AM EDT)

Goldman Sachs analyst Corinne Jenkins resumes coverage on Roivant Sciences (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login